 LupinPharmaceuticals | Lupin launches world's first triple combo COPD inhaler in India6 Oct 2026Regulatory Product Approval×7 | +0.8% — — | ₹2,028 | 92,712 Cr | 16.8vs 32.0 | 26.7% | +32.0% |
 Vedanta Aluminium MetalVAML | Vedanta Aluminium posts record Q2 production across all segments3 Oct 2026Regulatory Product Approval | -0.3% — — | ₹394 | 1.54 L Cr | 27.4 | — | — |
 Godrej PropertiesResidential Commercial Projects | MoEFCC revokes environmental clearance for Godrej Eternia Chandigarh project1 Oct 2026Regulatory Product Approval | +0.9% — — | ₹1,578 | 47,517 Cr | 29.7vs 21.3 | 11.4% | +16.5% |
 Aurobindo PharmaPharmaceuticals | Acrotech launches ADQUEY in U.S., sets up dermatology unit30 Sept 2026Regulatory Product Approval×2 | +0.2% — — | ₹1,682 | 96,782 Cr | 26.3vs 32.0 | 12.6% | +16.3% |
 ZF Com VE CTR SYS IndAuto Components & Equipments | ZF CVCS India secures NABL accreditation for Hemi Anechoic Chamber30 Sept 2026Regulatory Product Approval | -6.0% — — | ₹2,175 | 24,753 Cr | 10.0vs 27.0 | 18.4% | +9.3% |
 Motilal Oswal FinStockbroking & Allied | Motilal Oswal subsidiary gets SEBI custodian licence23 Sept 2026Regulatory Product Approval×2 | -1.2% +3.9% — | ₹1,070 | 64,430 Cr | 32.5vs 15.8 | — | +25.2% |
 PI IndustriesPesticides & Agrochemicals | PI Industries gets regulatory registration for new insecticide Pioxaniliprole21 Sept 2026Regulatory Product Approval | +2.7% -3.9% — | ₹2,200 | 33,440 Cr | 28.6vs 20.1 | 14.5% | -10.4% |
 Alkem LaboratoriesPharmaceuticals | Alkem launches NeuCeno for partial-onset seizures in India16 Sept 2026Regulatory Product Approval | +3.3% +2.2% — | ₹5,369 | 64,180 Cr | 29.8vs 32.0 | 17.8% | +10.9% |
 GMR AirportsAirport & Airport services | GMR Airports Aug'26 Traffic: 9.4 mn Pax, Up 0.9% YoY15 Sept 2026Regulatory Product Approval×2 | +2.2% +5.4% — | ₹91.15 | 96,245 Cr | 198.2 | 0.8% | +23.7% |
 Anand Rathi WealthFinancial Products Distributor | Anand Rathi subsidiary gets IFSCA fund management registration at GIFT City14 Sept 2026Regulatory Product Approval×2 | -0.1% -1.9% — | ₹2,127 | 35,317 Cr | 45.9vs 21.2 | 48.6% | +17.5% |
 Shilpa MedicarePharmaceuticals | Shilpa Medicare gets SEC nod for OERIS injectable marketing authorization11 Sept 2026Regulatory Product Approval | -3.4% +10.1% — | ₹1,071 | 20,945 Cr | 70.1vs 32.0 | 10.3% | +44.9% |
 Acutaas ChemicalsPharmaceuticals | Acutaas Chemicals gets patent for 2,4-Dimethylthiophenol process, total patents now 1110 Sept 2026Regulatory Product Approval×2 | -5.6% -5.5% — | ₹3,174 | 25,984 Cr | 67.3vs 32.0 | 27.5% | +59.1% |
 Sterlite TechnologiesSTLTECH | STL launches plenum-rated fiber trunk assemblies for AI data centers10 Sept 2026Regulatory Product Approval | -0.6% +0.7% — | ₹1,019 | 49,931 Cr | 205.0 | 3.0% | +87.4% |
 Bandhan BankPrivate Sector Bank | Bandhan Bank clarifies on credit card launch news, no undisclosed info8 Sept 2026Regulatory Product Approval | +1.4% +4.2% — | ₹163 | 26,259 Cr | 19.4vs 12.1 | — | — |
 Caplin Point LabPharmaceuticals | Caplin Point subsidiary gets GMP certification from Colombia's INVIMA1 Sept 2026Regulatory Product Approval | +4.4% +1.4% -4.7% | ₹2,639 | 20,053 Cr | 30.1vs 32.0 | 21.9% | +19.6% |
 L&T FinanceInvestment Company | IRDAI grants Corporate Agent (Composite) registration to L&T Finance1 Sept 2026Regulatory Product Approval | +2.5% -0.1% -14.8% | ₹260 | 65,177 Cr | 20.5vs 20.7 | — | +23.1% |
 Gland PharmaPharmaceuticals | USFDA inspection at Visakhapatnam facility closed with zero observations1 Sept 2026Regulatory Product Approval×2 | +0.8% +1.5% +0.6% | ₹3,154 | 52,028 Cr | 46.0vs 32.0 | 13.4% | +19.6% |
 NLC IndiaPower Generation | NLC India wins mineral licence for two blocks in Telangana31 Aug 2026Regulatory Product Approval | +3.2% +1.1% -5.3% | ₹250 | 34,687 Cr | 10.4vs 21.2 | 5.4% | +23.3% |
 Biocon Limited.Pharmaceuticals | Biocon Biologics gets Japan approval for Pegfilgrastim biosimilar25 Aug 2026Regulatory Product Approval×5 | +2.0% -1.7% -6.6% | ₹360 | 58,669 Cr | 105.9vs 32.0 | 0.9% | +10.0% |
 Glenmark PharmaceuticalsPharmaceuticals | Glenmark's US arm launches Calcium Gluconate Injection in US market21 Aug 2026Regulatory Product Approval×4 | +2.5% +5.2% +5.4% | ₹2,293 | 64,711 Cr | 36.0vs 32.0 | 14.7% | +23.1% |
 Anant RajResidential Commercial Projects | Anant Raj gets RERA registration for Gurugram luxury housing project20 Aug 2026Regulatory Product Approval | -3.1% -7.5% -6.0% | ₹612 | 22,020 Cr | 37.1vs 21.3 | 10.2% | +6.6% |
 Colgate PalmolivePersonal Care | Colgate PerioGard earns ISP Seal of Acceptance — first in India18 Aug 2026Regulatory Product Approval | +0.4% -3.9% -1.2% | ₹1,763 | 47,954 Cr | 35.6vs 35.6 | 107.1% | +11.8% |
 Zydus LifesciencesPharmaceuticals | Zydus launches REVAHALE, India's first once-daily nebulised LAMA for COPD10 Aug 2026Regulatory Product Approval×2 | +7.2% -1.0% +0.2% | ₹1,158 | 1.16 L Cr | 25.8vs 32.0 | 18.0% | +22.0% |
 DelhiveryLogistics Solution Provider | RBI grants NBFC registration to Delhivery Financial Services subsidiary4 Aug 2026Regulatory Product Approval×2 | -0.9% -1.4% -3.5% | ₹399 | 29,887 Cr | 319.3vs 16.0 | 1.2% | +27.8% |
 Sun Pharmaceutical IndPharmaceuticals | Sun Pharma gets Brazil approval to market semaglutide for diabetes29 Jul 2026Regulatory Product Approval×4 | -0.3% -2.4% -0.3% | ₹1,780 | 4.27 L Cr | 35.3vs 32.0 | 17.5% | +10.5% |
 Dr. Reddy S LaboratoriesPharmaceuticals | Dr Reddy's confirms Thailand approval for gonorrhoea drug NUZOLVENCE29 Jul 2026Regulatory Product Approval | +0.9% +3.0% +1.7% | ₹1,202 | 1.00 L Cr | 31.1vs 32.0 | 13.0% | -5.5% |
 CiplaPharmaceuticals | Cipla gets US FDA approval for Generic Advair Diskus27 Jul 2026Regulatory Product Approval | +4.2% +4.4% 0.0% | ₹1,332 | 1.08 L Cr | 31.9vs 32.0 | 14.7% | +2.3% |
 Timken IndiaAbrasives & Bearings | Please find attached press release regarding BIS Licenses obtained by Timken India Limited.
This is for your information and record.13 Jul 2026Regulatory Product Approval×2 | +0.5% -2.2% +3.7% | ₹3,135 | 23,583 Cr | 70.9vs 90.2 | 18.4% | — |
